Cargando…
How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study
INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomat...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118273/ https://www.ncbi.nlm.nih.gov/pubmed/33984044 http://dx.doi.org/10.1371/journal.pone.0251645 |
_version_ | 1783691714957934592 |
---|---|
author | Ross, Jonathan Ingabire, Charles Umwiza, Francine Gasana, Josephine Munyaneza, Athanase Murenzi, Gad Nsanzimana, Sabin Remera, Eric Akiyama, Matthew J. Anastos, Kathryn M. Adedimeji, Adebola |
author_facet | Ross, Jonathan Ingabire, Charles Umwiza, Francine Gasana, Josephine Munyaneza, Athanase Murenzi, Gad Nsanzimana, Sabin Remera, Eric Akiyama, Matthew J. Anastos, Kathryn M. Adedimeji, Adebola |
author_sort | Ross, Jonathan |
collection | PubMed |
description | INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomatic, and they may view the relative benefits and risks of ART differently than those initiating at more advanced disease stages. To date, patient perspectives of initiating care under Treat All in sub-Saharan Africa have not been well described. METHODS: From September 2018 to March 2019, we conducted individual, semi-structured, qualitative interviews with 37 patients receiving HIV care in two health centers in Kigali, Rwanda. Data were analyzed using a mixed deductive and inductive thematic analysis approach to describe perceived barriers to, facilitators of and acceptability of initiating and adhering to ART rapidly under Treat All. RESULTS: Of 37 participants, 27 were women and the median age was 31 years. Participants described feeling traumatized and overwhelmed by their HIV diagnosis, resulting in difficulty accepting their HIV status. Most were prescribed ART soon after diagnosis, yet fear of lifelong medication and severe side effects in the immediate period after initiating ART led to challenges adhering to therapy. Moreover, because many PLWH initiated ART while healthy, taking medications and attending appointments were visible signals of HIV status and highly stigmatizing. Nonetheless, many participants expressed enthusiasm for Treat All as a program that improved health as well as health equity. CONCLUSION: For newly-diagnosed PLWH in Rwanda, initiating ART rapidly under Treat All presents logistical and emotional challenges despite the perceived benefits. Our findings suggest that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART. |
format | Online Article Text |
id | pubmed-8118273 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-81182732021-05-24 How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study Ross, Jonathan Ingabire, Charles Umwiza, Francine Gasana, Josephine Munyaneza, Athanase Murenzi, Gad Nsanzimana, Sabin Remera, Eric Akiyama, Matthew J. Anastos, Kathryn M. Adedimeji, Adebola PLoS One Research Article INTRODUCTION: HIV treatment guidelines recommend that all people living with HIV (PLWH) initiate antiretroviral therapy (ART) as soon as possible after diagnosis (Treat All). As Treat All is more widely implemented, an increasing proportion of PLWH are likely to initiate ART when they are asymptomatic, and they may view the relative benefits and risks of ART differently than those initiating at more advanced disease stages. To date, patient perspectives of initiating care under Treat All in sub-Saharan Africa have not been well described. METHODS: From September 2018 to March 2019, we conducted individual, semi-structured, qualitative interviews with 37 patients receiving HIV care in two health centers in Kigali, Rwanda. Data were analyzed using a mixed deductive and inductive thematic analysis approach to describe perceived barriers to, facilitators of and acceptability of initiating and adhering to ART rapidly under Treat All. RESULTS: Of 37 participants, 27 were women and the median age was 31 years. Participants described feeling traumatized and overwhelmed by their HIV diagnosis, resulting in difficulty accepting their HIV status. Most were prescribed ART soon after diagnosis, yet fear of lifelong medication and severe side effects in the immediate period after initiating ART led to challenges adhering to therapy. Moreover, because many PLWH initiated ART while healthy, taking medications and attending appointments were visible signals of HIV status and highly stigmatizing. Nonetheless, many participants expressed enthusiasm for Treat All as a program that improved health as well as health equity. CONCLUSION: For newly-diagnosed PLWH in Rwanda, initiating ART rapidly under Treat All presents logistical and emotional challenges despite the perceived benefits. Our findings suggest that optimizing early engagement in HIV care under Treat All requires early and ongoing intervention to reduce trauma and stigma, and promote both individual and community benefits of ART. Public Library of Science 2021-05-13 /pmc/articles/PMC8118273/ /pubmed/33984044 http://dx.doi.org/10.1371/journal.pone.0251645 Text en © 2021 Ross et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Ross, Jonathan Ingabire, Charles Umwiza, Francine Gasana, Josephine Munyaneza, Athanase Murenzi, Gad Nsanzimana, Sabin Remera, Eric Akiyama, Matthew J. Anastos, Kathryn M. Adedimeji, Adebola How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title | How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title_full | How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title_fullStr | How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title_full_unstemmed | How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title_short | How early is too early? Challenges in ART initiation and engaging in HIV care under Treat All in Rwanda—A qualitative study |
title_sort | how early is too early? challenges in art initiation and engaging in hiv care under treat all in rwanda—a qualitative study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8118273/ https://www.ncbi.nlm.nih.gov/pubmed/33984044 http://dx.doi.org/10.1371/journal.pone.0251645 |
work_keys_str_mv | AT rossjonathan howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT ingabirecharles howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT umwizafrancine howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT gasanajosephine howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT munyanezaathanase howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT murenzigad howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT nsanzimanasabin howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT remeraeric howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT akiyamamatthewj howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT anastoskathrynm howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy AT adedimejiadebola howearlyistooearlychallengesinartinitiationandengaginginhivcareundertreatallinrwandaaqualitativestudy |